We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.39B
AUM Growth
+$526M
Cap. Flow
+$586M
Cap. Flow %
17.28%
Top 10 Hldgs %
16.92%
Holding
1,543
New
205
Increased
822
Reduced
368
Closed
82
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OA
251
DELISTED
Orbital ATK, Inc.
OA
$2.65M 0.08%
20,791
NVS icon
252
Novartis
NVS
$298B
$2.65M 0.08%
31,355
+6,219
+25% +$503K
BSJF
253
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
$2.63M 0.08%
99,354
+3,893
+4% +$104K
PIZ icon
254
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$730M
$2.63M 0.08%
107,673
-4,509
-4% -$115K
TMV icon
255
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$195M
$2.6M 0.08%
24,357
+1,983
+9% +$224K
VOT icon
256
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
$2.59M 0.08%
26,872
+2,072
+8% +$201K
IWB icon
257
iShares Russell 1000 ETF
IWB
$50.2B
$2.58M 0.08%
23,439
+1,076
+5% +$119K
NVO
258
Novo Nordisk
NVO
$209B
$2.58M 0.08%
108,158
+3,806
+4% +$87.6K
HAL icon
259
Halliburton
HAL
$28B
$2.56M 0.08%
39,765
+10,673
+37% +$732K
SBUX icon
260
Starbucks
SBUX
$119B
$2.53M 0.07%
67,014
+8,634
+15% +$334K
ESRX
261
DELISTED
Express Scripts Holding Company
ESRX
$2.52M 0.07%
35,754
+2,517
+8% +$179K
SPXL icon
262
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.29B
$2.51M 0.07%
129,360
+2,560
+2% +$49.9K
KRFT
263
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$2.5M 0.07%
44,276
-829
-2% -$47.9K
XLY icon
264
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$2.48M 0.07%
74,342
+13,430
+22% +$454K
STX icon
265
Seagate
STX
$182B
$2.48M 0.07%
43,240
+3,990
+10% +$236K
UGA icon
266
United States Gasoline Fund
UGA
$136M
$2.47M 0.07%
+45,298
New +$2.61M
YUM icon
267
Yum! Brands
YUM
$39.7B
$2.46M 0.07%
47,619
+19,393
+69% +$1.03M
ADRD
268
DELISTED
Invesco BLDRS Developed Markets 100 ADR Index Fund
ADRD
$2.43M 0.07%
100,253
+3,342
+3% +$83.6K
CLX icon
269
Clorox
CLX
$13B
$2.42M 0.07%
25,250
+4,026
+19% +$364K
RWR icon
270
State Street SPDR Dow Jones REIT ETF
RWR
$1.87B
$2.42M 0.07%
30,281
+2,499
+9% +$209K
EDIV icon
271
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$2.41M 0.07%
65,910
-1,680
-2% -$67K
WBA
272
DELISTED
Walgreens Boots Alliance
WBA
$2.41M 0.07%
40,651
+7,646
+23% +$501K
PGX icon
273
Invesco Preferred ETF
PGX
$3.76B
$2.41M 0.07%
166,380
+34,244
+26% +$497K
RWL icon
274
Invesco S&P 500 Revenue ETF
RWL
$9.95B
$2.4M 0.07%
62,125
+36,169
+139% +$1.41M
GSK icon
275
GSK
GSK
$104B
$2.39M 0.07%
41,586
+6,204
+18% +$380K

Similar funds

Cambridge Investment Research Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Cambridge Investment Research Advisors held 1,543 positions worth $3.39B, up 18% from $2.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors deployed $586M of net new capital in Q3 2014, opening 205 new positions and adding to 822 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 556,997 shares worth $101M.

By sector, the portfolio is most concentrated in Energy at 5.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $20M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2014 buy was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
  • Cambridge Investment Research Advisors added most to Barclays Bank Plc in Q3 2014, an estimated $45.8M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2014 reduction was iShares Russell 3000 ETF, cutting an estimated $20M.
  • Cambridge Investment Research Advisors fully exited iShares MSCI Taiwan ETF in Q3 2014, selling an estimated $1.83M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $3.39B portfolio in Q3 2014.
  • Cambridge Investment Research Advisors opened 205 new positions and closed 82 in Q3 2014.
  • Cambridge Investment Research Advisors's portfolio value rose 18% quarter-over-quarter to $3.39B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2014, filed 5 Nov 2014.